Family Caregivers in Underserved Populations Providing Complex Cancer Care

Study summary

This clinical trial develops and tests a model of family caregiver education focused on the role of underserved family caregivers as providers of complex care in the home. Cancer patients have symptoms from their cancer or treatment and are then supported by family caregivers at home with tasks requiring technical skill. Family caregivers are often asked to provide complex care whether it involves decisions about managing symptoms or providing technical care for ports/pumps, tubes, or devices. Family caregivers often are not given enough information on how to provide care for patients at home needing complex care. The results from this study may help researchers refine and improve the intervention for caregivers through future research for caregivers on a much larger scale.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedEducational Intervention and Quality-of-Life Assessment

Plus 1 other study approaches.

Who it may be forEarly-stage or resectable · Locally advanced · Metastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jan 5, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?City of Hope Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: City of Hope Medical Center
Interventions being studied: Other: Educational Intervention; Other: Quality-of-Life Assessment; Other: Questionnaire Administration

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Early-stage or resectable→Locally advanced→Metastatic or stage IV→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

PATIENT: Diagnosis of any stage lung or gynecologic (gyn) cancer
PATIENT: Read and understand English
PATIENT: Requires either complex physical care or complex decision making regarding symptoms
PATIENT: Age 18 years or older
FCG: Designated by the patient as their caregiver
FCG: Read and understand English
FCG: Age 18 years or older
FCG: Providing complex care and/or complex decision-making

Reasons someone may not be able to joinExclusion criteria

Inability to read and understand English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

City of Hope Medical CenterDuarte, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 5, 2024. Always confirm current availability with the study team.

View original record ↗